INTEGRATED CORE STRATEGIES (US) LLC 13D and 13G filings for Lexeo Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-28 4:03 pm Purchase | 2025-04-22 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | INTEGRATED CORE STRATEGIES (US) LLC | 1,933,379 5.800% | 1,933,379 (New Position) | Filing |